Mirum Pharmaceuticals, Inc.
Clinical trials sponsored by Mirum Pharmaceuticals, Inc., explained in plain language.
-
New shot offers hope for controlling tough liver virus
Disease control OngoingThis study is testing a new drug called BJT-778 (brelovitug) for people with chronic Hepatitis D, a serious liver infection. About 150 participants will either start the weekly or monthly injections right away or wait 24 weeks before beginning treatment. The main goal is to see i…
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug trial targets debilitating itch in liver disease
Symptom relief OngoingThis study is testing whether an investigational drug called volixibat can safely reduce the severe itching (pruritus) experienced by people with primary sclerosing cholangitis (PSC), a chronic liver disease. The trial involves 182 participants who will receive either the drug or…
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC